ERYTECH Announces Launch of Investigator-Initiated Phase 2 Study of eryaspase (GRASPA®) for ALL

April 4, 2017

LYON, France--(BUSINESS WIRE)--Apr. 4, 2017-- Regulatory News: ERYTECH Pharma (Paris:ERYP) (ADR:EYRYY) a French clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blo

Read More

Erytech: Information Related to Total Number of Voting Rights and Shares Composing the Share Capital – March 2017

April 4, 2017

Article 223-16 of general regulation of French Autorité des Marchés Financiers LYON, France--(BUSINESS WIRE)--Apr. 4, 2017-- Regulatory News: Erytech (Paris:ERYP) (ADR:EYRYY): Date

Read More